Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-27 @ 9:29 PM
Study NCT ID:
NCT02215161
Status:
TERMINATED
Last Update Posted:
2018-06-26
First Post:
2014-07-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer
Sponsor:
University of California, San Francisco
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
14552
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |